EE315 Cost-Effectiveness of Obicetrapib As Adjunctive Therapy Compared to Maximally Tolerated Statins for Lowering LDL-c
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.614
https://www.valueinhealthjournal.com/article/S1098-3015(24)00729-0/fulltext
Title :
EE315 Cost-Effectiveness of Obicetrapib As Adjunctive Therapy Compared to Maximally Tolerated Statins for Lowering LDL-c
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00729-0&doi=10.1016/j.jval.2024.03.614
First page :
Section Title :
Open access? :
No
Section Order :
10090